Clinical outcomes and impact of mismatch repair deficiency (dMMR) in patients with pT4N0 colon cancer (CC): Data from a large, consecutive, multicenter, real-world cohort.

Authors

Alberto Puccini

Alberto Puccini

IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Medical Oncology and Hematology Unit, Rozzano, Italy

Alberto Puccini , Daniele Rossini , Valentina Daprà , Francesco Schietroma , Serena Perazzo , Anna Ceccarelli , Federica Zoratto , Manuel Costantini , Vincenzo Formica , Michela Rofei , Gianluca Mauri , Erica Bonazzina , Emiliano Tamburini , Carlo Signorelli , Lorenzo Antonuzzo , Camilla Damonte , Antonino Spinelli , Giampaolo Tortora , Armando Santoro , Lisa Salvatore

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Local-Regional Disease

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 3619)

DOI

10.1200/JCO.2024.42.16_suppl.3619

Abstract #

3619

Poster Bd #

282

Abstract Disclosures

Similar Posters

First Author: Yasuhide Yamada

First Author: Yuta Ushida

Poster

2014 ASCO Annual Meeting

A marker-driven phase II trial of neoadjuvant chemotherapy in locally advanced colon cancer.

A marker-driven phase II trial of neoadjuvant chemotherapy in locally advanced colon cancer.

First Author: Anders Kristian Moeller Jakobsen

First Author: Praveen Ramakrishnan Geethakumari